Genitourinary Cancers | Tumor

5 FDA Approvals for Solid Tumors in Early 2024

April 5th 2024, 7:00pm

Article

Since January 2024, the Food and Drug Administration has approved several treatments and combinations for solid tumors.

Immunotherapy Improves Survival in Metastatic Bladder Cancer

April 4th 2024, 9:00pm

Article

Treatment with immune checkpoint inhibitors has improved survival outcomes for patients with metastatic bladder cancer, compared with chemotherapy.

Race Associated With Kidney Cancer Survival Disparities

March 28th 2024, 7:00pm

Article

Across disease stages, Black patients with renal cell carcinoma experience worse survival outcomes than White patients, research has shown.

Radiotherapy A Noninvasive Option for Patients With Kidney Cancer

March 27th 2024, 3:00pm

Article

Patients with inoperable kidney cancer saw significant results in local control and cancer-specific survival with stereotactic ablative body radiotherapy.

Appreciating Life More Than a Career After Cancer

March 21st 2024, 5:00pm

Article

When life hands you cancer lemons, what flavored lemonade do you make?

Multiple Opinions Are ‘Crucial’ for Muscle-Invasive Bladder Cancer

March 15th 2024, 9:00pm

Article

Quality of life, sexual outcomes and self-image should be considered before choosing a treatment option for muscle-invasive bladder cancer, an expert said.

Olivia Munn Discusses Breast Cancer, Christine Brinkley Diagnosed With Basal Cell Carcinoma and More

March 15th 2024, 3:00pm

Article

From Oliva Munn and Christine Brinkley discussing their cancer to Donnie Iris returning to the stage after his experience with the disease, here is what’s happening in the oncology space this week.

ChatGPT Not a Substitute for Urologist When Discussing Kidney Cancer

March 12th 2024, 3:00pm

Article

Artificial intelligence platform ChatGPT is capable of providing “widely understandable and accessible” answers about kidney cancer, but experts express caution.

The Prostate Cancer Demon

March 12th 2024, 1:00pm

Article

My prostate cancer has come back and stronger, but so have I.

FDA Approves Opdivo Plus Chemo for Unresectable or Metastatic Bladder Cancer

March 7th 2024, 5:29pm

Article

The Food and Drug Administration (FDA) has approved Opdivo (nivolumab) in combination with cisplatin and gemcitabine for the first-line treatment of adults with unresectable or metastatic bladder cancer, the agency has announced.